Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is a law firm dedicated to advancing ideas, discoveries, and innovations that drive businesses around the world. From offices in the United States, Europe, and Asia, Finnegan works with leading innovators to protect, advocate, and leverage their most important intellectual property (IP) assets.
Your LinkedIn Connections
with the authors
Generating articles
loading
Generating authors
loading
Generating guides
loading
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Marking a manufactured good with a patent number puts potential infringers on notice of the patentee’s rights.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Patents are jurisdiction dependent, and beneficial strategies under one country’s laws and rules may be met with resistance in another jurisdiction.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
This latest series of webinars will take you through a detailed discussion of patent prosecution strategies and practical examples within key industries.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Join Finnegan attorneys Justin Hasford, Matthew Hlinka, and Priya Dalal as they explore recent developments in patent case law with a focus on the pharmaceutical, chemical, and biotech fields. During this free interactive webinar, you will be apprised of
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Arpita Bhattacharyya, Ph.D. is a partner who has been recognized as a WIPR Influential Women in IP Trailblazer.
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Ten years have passed since the America Invents Act (AIA) was signed into law, ushering in wide-reaching changes to the field of patent law, from the first-to-file standard for inventorship...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Prudent companies monitor their rivals’ patents. When identifying patents of interest, opinion letters can be useful for business planning, for willfulness purposes in the event of litigation ...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
On January 7, 2019, the USPTO issued the long-awaited 2019 Revised Patent Subject Matter Eligibility Guidance (“2019 PEG”) ...
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
As recognized by the U.S. Food and Drug Administration (FDA), “[b]iological products often represent the cutting edge of biomedical research.”
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Joint ventures and other collaborations between companies are becoming more and more important across the energy sector.
Contact Details
Washington, DC
Email Website
901 New York Avenue, NW
Washington, DC
United States
Telephone: 1-202-4084000